Healthy Volunteers for HIV Prevention Research Study
Researchers at The Fenway Institute are partnering with volunteers ages 18-65 to evaluate an investigational study medicine to prevent HIV. Join our compensated study today!
Fast Facts
healthy individuals
low risk of STI
18-65 years old
Compensation Provided
Conducted in boston, MA
Study Background
Researchers want to learn more about an investigational study medicine which is a type of PrEP (pre-exposure prophylaxis). PrEP is medicine that may help lower the chance of becoming infected with human immunodeficiency virus (HIV) in people at risk of being exposed to the virus.
In this clinical research study, researchers want to learn about:
- The safety of different doses of the investigational study medicine
- How the investigational study medicine works in the body
- About any side effects from the investigational study medicine (tolerability)
If you are in good health, 18-65 years old, HIV negative, and have a low risk of getting an HIV infection, you may be able to join this study.
Your participation may help researchers improve approaches for HIV prevention. Advance research today and join our compensated study!
Study Background
Researchers want to learn more about an investigational study medicine which is a type of PrEP (pre-exposure prophylaxis). PrEP is medicine that may help lower the chance of becoming infected with human immunodeficiency virus (HIV) in people at risk of being exposed to the virus.
In this clinical research study, researchers want to learn about:
- The safety of different doses of the investigational study medicine
- How the investigational study medicine works in the body
- About any side effects from the investigational study medicine (tolerability)
If you are in good health, 18-65 years old, HIV negative, and have a low risk of getting an HIV infection, you may be able to join this study.
Your participation may help researchers improve approaches for HIV prevention. Advance research today and join our compensated study!
Additional Information
- Test the safety of different doses of the medicine when given once each month
- Measure what happens as the medicine goes through the body
You may qualify for this study if you meet the following criteria.
Key Criteria:
- Ages 18-65
- Healthy individuals
- Low risk of STI
- If applicable, use effective contraception
- If female, not pregnant or breastfeeding
- No stimulant or illicit injection drug use, excluding cannabis
You are considered low-risk for STI (sexually transmitted infections) if, in the past 12 months:
- You have not had sex with a partner who is HIV positive or has unknown HIV status
- You have not used stimulants or illicit injection drugs (including poppers, not including marijuana)
- You have not had any new STI diagnoses
- You have had 3 or fewer different sexual partners
- You have no history of antiretrovirals for PrEP or PEP
If you join this study, you will visit the study site up to 15 times over 34 weeks (about 8 months), including the screening visit. During visits, you will take your assigned investigational study medicine (or placebo). A placebo looks like the investigational study medicine but has no active ingredients. You will also undergo medical tests, such as:
- Physical exams
- Urine (pee) tests
- Blood draws
- Pregnancy tests, if you are able to get pregnant
- Electrocardiograms, which is a test to look for signs of heart problems
After you stop getting the investigational study medicine (or placebo), you will enter the follow-up period. You will visit the study site up to 4 times over 2 months.
